Stemcell, 200-0196, Diseased Human Peripheral Blood Products, Acute Myeloid Leukemia (AML)

Start immuno-oncology experiments confidently with a reliable supply of ethically sourced, cryopreserved peripheral blood products from donors diagnosed with acute myeloid leukemia (AML). Options include cancer-sourced frozen peripheral blood mononuclear cells (MNCs or PBMCs) and custom-isolated frozen products such as plasma and serum. We help you get the cells you need with personalized service and flexible delivery times.

Cancer-sourced primary human MNCs are isolated from peripheral blood, leukapheresis, or whole blood samples using density gradient separation or red blood cell lysis and cryopreserved in animal component-free CryoStor® CS10 medium. All peripheral blood products are obtained from donors diagnosed with AML using Institutional Review Board (IRB)-approved consent forms and protocols. Additional documentation to meet institutional requirements and high-resolution HLA typing (Class I and Class II alleles and CMV status) are available upon request. Sodium heparin (Na-Hep), ethylenediaminetetraacetic acid (EDTA), or acid-citrate-dextrose solution A (ACDA) is added during collection as an anticoagulant.

Contact [email protected] if high-resolution HLA typing (Class I and Class II alleles and CMV status) is required or for donor specifications (BMI category, smoking status, ethnicity, etc.). For more information, browse frequently asked questions (FAQs) on primary cells.